Related references
Note: Only part of the references are listed.Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease
Owen A. Moore et al.
RHEUMATOLOGY (2013)
Clinical Course of Lung Physiology in Patients With Scleroderma and Interstitial Lung Disease Analysis of the Scleroderma Lung Study Placebo Group
Dinesh Khanna et al.
ARTHRITIS AND RHEUMATISM (2011)
Predicting Treatment Outcomes and Responder Subsets in Scleroderma-Related Interstitial Lung Disease
Michael D. Roth et al.
ARTHRITIS AND RHEUMATISM (2011)
Quantitative texture-based assessment of one-year changes in fibrotic reticular patterns on HRCT in scleroderma lung disease treated with oral cyclophosphamide
Hyun J. Kim et al.
EUROPEAN RADIOLOGY (2011)
Treatment of Scleroderma-Interstitial Lung Disease With Cyclophosphamide Is Associated With Less Progressive Fibrosis on Serial Thoracic High-Resolution CT Scan Than Placebo Findings From the Scleroderma Lung Study
Jonathan Goldin et al.
CHEST (2009)
HRCT and scleroderma: semiquantitative evaluation of lung damage and functional abnormalities
M. Bellia et al.
RADIOLOGIA MEDICA (2009)
Classification of parenchymal abnormality in scleroderma lung using a novel approach to denoise images collected via a Multicenter study
Hyun J. Kim et al.
ACADEMIC RADIOLOGY (2008)
Interstitial lung disease in systemic sclerosis - A simple staging system
Nicole S. L. Goh et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2008)
High-resolution CT scan findings in patients with symptomatic scleroderma-related interstitial lung disease
Jonathan G. Goldin et al.
CHEST (2008)
Pulmonary involvement in systemic sclerosis: Associations with genetic, serologic, sociodemographic, and behavioral factors
Terry A. McNearney et al.
ARTHRITIS & RHEUMATISM-ARTHRITIS CARE & RESEARCH (2007)
Validity of the Saint George's Respiratory Questionnaire in the evaluation of the health-related quality of life in patients with interstitial lung disease secondary to systemic sclerosis
L. Beretta et al.
RHEUMATOLOGY (2007)
Six-minute walk test for the evaluation of pulmonary disease severity in scleroderma patients
Wander O. Villalba et al.
CHEST (2007)
A multicenter, prospective, randomized, double-blind, placebo-controlled trial of corticosteroids and intravenous cyclophosphamide followed by oral azathioprine for the treatment of pulmonary fibrosis in scleroderma
Rachel K. Hoyles et al.
ARTHRITIS AND RHEUMATISM (2006)
Cyclophosphamide versus placebo in scleroderma lung disease
Donald P. Tashkin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Standardisation of the single-breath determination of carbon monoxide uptake in the lung
N MacIntyre et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Standardisation of spirometry
MR Miller et al.
EUROPEAN RESPIRATORY JOURNAL (2005)
Internal validation of predictive models: Efficiency of some procedures for logistic regression analysis
EW Steyerberg et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2001)
Share Paper
